Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of bevacizumab in combination with capecitabine and radiotherapy as preoperative treatment in locally advanced resectable rectal cancer
2007-000456-13Phase 2Completed
- Sponsor
- Institut Català d'Oncologia
- Start
- Mar 2010
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of bevacizumab in rectal cancer, sponsored by Institut Català d'Oncologia. Primary endpoint: Pathologic complete response rate. Started Mar 2010; status: completed.
02
Drugs
bevacizumab
03
Conditions
rectal cancer
Beyond the preview
Go deeper on 2007-000456-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000456-13.